Answers are grounded in this paper and cite their sources.
Review examines liver transplantation outcomes for nonresectable liver metastases, highlighting new therapeutic advancements.
Patients with nonresectable liver metastases from colorectal cancer have few therapeutic options and a dismal prognosis. Although liver transplantation for this indication has historically a poor reputation, recent advances in the field of chemotherapy and immunosuppression have paved the way to revisit the concept. New data have shown promising results that need to be validated in several ongoing clinical trials. Since liver grafts represent a scarce resource, several new tools are being explored to expand the donor pool for this indication. The purpose of this review is to present all current available data and perspectives about liver transplantation for nonresectable liver metastases from colorectal cancer.
No takes yet. Share an insight, caveat, or question.
Puia‐Negulescu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: